PPLPHARMA
Piramal Pharma Limited
171.28
+4.76 (2.86%)
L: 166.55
H: 171.9
Technical Analysis - PPLPHARMA
19 Dec 2025 03:34 PM IST
Lot Size
2500
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Fibonacci | 163.13 | 164.54 | 165.41 | 166.81 | 168.22 | 169.09 | 170.49 |
| Bollinger band (1,2) | - | 173.05 | 177.81 | 177.81 | 177.81 | 182.57 | - |
Technical Indicator
| Name | Value |
|---|---|
| Adx(14) | 0.00 |
| Rsi(14) | 34.94 |
| Stoch Rsi(14) | 0.93 |
| MACD(12,26) | -6.20 |
| Williams %R | -72.72 |
| ROC | -7.35 |
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA 9 | 170.73 | 171.60 |
| MA 20 | 177.81 | 176.96 |
| MA 50 | 189.27 | 185.39 |
| MA 100 | 192.40 | 191.75 |
| MA 200 | 200.55 | 197.46 |
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Fibonacci | 159.33 | 162.92 | 165.13 | 168.71 | 172.30 | 174.51 | 178.09 |
| Bollinger band (1,2) | - | 173.05 | 177.81 | 177.81 | 177.81 | 182.57 | - |
Technical Indicator
| Name | Value |
|---|---|
| Adx(14) | 0.00 |
| Rsi(14) | 36.91 |
| Stoch Rsi(14) | 0.74 |
| MACD(12,26) | -6.38 |
| Williams %R | -74.42 |
| ROC | -7.35 |
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA 9 | 170.73 | 171.60 |
| MA 20 | 177.81 | 176.98 |
| MA 50 | 188.74 | 186.21 |
| MA 100 | 204.88 | 186.32 |
| MA 200 | NaN | NaN |
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Fibonacci | 149.53 | 158.73 | 164.41 | 173.61 | 182.81 | 188.49 | 197.69 |
| Bollinger band (1,2) | - | 173.05 | 177.81 | 177.81 | 177.81 | 182.57 | - |
Technical Indicator
| Name | Value |
|---|---|
| Adx(14) | 0.00 |
| Rsi(14) | 40.52 |
| Stoch Rsi(14) | 0.56 |
| MACD(12,26) | -5.35 |
| Williams %R | -74.42 |
| ROC | -7.35 |
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA 9 | 170.73 | 171.60 |
| MA 20 | 177.81 | 176.76 |
| MA 50 | 194.43 | 178.85 |
| MA 100 | NaN | NaN |
| MA 200 | NaN | NaN |































































































































































































































